This paper introduces the Westlake Precision Birth Cohort (WeBirth), a novel prospective study integrating multiomics, wearable sensors, and standardized testing to understand personalized nutrition and lifestyle impacts on gestational diabetes (GDM) and its long-term consequences for mothers and offspring. The goal is to pave the way for precision nutrition strategies to improve GDM management and health outcomes.
What Problem Does This Paper Address?
Gestational diabetes mellitus (GDM) is a growing global health concern, significantly increasing the risk of adverse pregnancy outcomes and long-term complications like type 2 diabetes for both mothers and their children. While lifestyle interventions are key, current recommendations are often generalized. The paper highlights a critical gap: a lack of understanding regarding how individual pregnant women with GDM respond differently to dietary and lifestyle interventions. Existing birth cohorts, while large, often lack the detailed multiomics and continuous physiological monitoring needed to unravel these personalized responses. This limits the development of truly precise nutritional guidance for GDM management.
Methods
The WeBirth cohort employs a multi-faceted approach:
Prospective Cohort Design: Following pregnant women diagnosed with GDM and their offspring over several years.
Wearable Technology: Utilizing Axivity AX3 accelerometers for objective physical activity measurement and continuous glucose monitoring (CGM) devices (Freestyle Libre Pro) for detailed blood glucose tracking over 14-day periods.
Standardized Testing Meals: Participants consume precisely defined meals in a clinical setting to observe immediate glycemic responses.
Comprehensive Data Collection:
Dietary Intake: Assessed via Food Frequency Questionnaires (FFQ), 24-hour dietary recalls, and electronic dietary logs.
Physiological Data: Regular measurements of blood pressure, weight, and anthropometrics.
Biological Samples: Collection of saliva, blood, urine, stool, meconium, colostrum, cord blood, and placenta for multiomics analysis (genomics, proteomics, microbiome).
Psychosocial Data: Questionnaires assessing sleep quality, anxiety, depression, and other psychological factors.
Longitudinal Follow-up: Extended monitoring of mothers and children at 3-year intervals up to age 5, collecting similar data to assess long-term health trajectories.
Datasets
The paper describes the establishment of the Westlake Precision Birth Cohort (WeBirth). This is a newly initiated prospective cohort study.
Target Sample Size: Approximately 2000 pregnant women diagnosed with GDM.
Recruitment Status: As of October 2022, 1715 women had been included, with complete baseline data for 1621.
Geographic Focus: Participants are recruited from Hangzhou, China.
Data Types: The cohort collects a wide array of data including demographic, lifestyle, dietary, physical activity, continuous glucose monitoring, anthropometric, psychosocial, clinical, and multiomics data (genomics, proteomics, microbiome) from both mothers and their offspring.
Key Insights and Ideas
The "One-Size-Fits-All" Approach is Insufficient: The core idea is that individual responses to diet and lifestyle vary significantly, especially in GDM, necessitating a personalized approach.
Multi-Omics Integration is Crucial: Combining genomic, proteomic, and microbiome data with physiological and lifestyle information offers a holistic view of GDM pathophysiology and progression.
Wearable Technology as a Game-Changer: Continuous glucose monitoring and accelerometers provide objective, real-time data that traditional methods cannot capture, enabling a deeper understanding of dynamic responses.
Bridging the Gap Between Nutrition and Outcomes: The study aims to directly link personalized glycemic responses to dietary intake and physical activity with specific birth outcomes and long-term health risks.
Long-Term Impact on Offspring: Recognizing that GDM has lasting effects on children's health, the cohort's extended follow-up is vital for understanding intergenerational health trajectories.
Key Results
As this paper describes a study protocol, specific quantitative results from the cohort's analysis are not yet available. However, the paper details the planned data collection and analysis strategies. The recruitment has successfully enrolled over 1600 participants, demonstrating feasibility. The detailed methodology outlines how the study will generate data to address its objectives.
Limitations and Future Work
Generalizability: The cohort currently includes only Chinese participants, limiting the direct generalizability of findings to other ethnicities.
Lack of Normal Control Group: At this stage, the study focuses solely on GDM pregnancies, lacking a comparison group of women without GDM.
Observational Nature: The study design is observational, meaning it can identify associations but cannot establish definitive causality.
Future Work: The authors intend to leverage the rich, integrated dataset to:
Develop personalized nutritional and lifestyle recommendations for GDM patients.
Investigate the associations between dietary intake, physical activity, glucose fluctuations, and adverse birth outcomes.
Explore links between CGM data, body composition, and offspring development.
Identify risk factors (including microbiome) for developing type 2 diabetes post-pregnancy.
Contribute significantly to the understanding of precision nutrition for GDM and long-term maternal-fetal health.
Summary updated
Abstract
We established a prospective birth cohort, the Westlake Precision Birth Cohort (WeBirth), based on 2000 pregnant women with gestational diabetes mellitus (GDM) in the second trimester and their offspring. The WeBirth provides a new framework for prospective birth cohort study with sophisticated integration of precision nutrition, wearable devices, and multiomics data collection among patients with GDM. Gestational diabetes mellitus (GDM) is a common pregnancy complication, and its prevalence has been increasing worldwide [1]. Specifically, the prevalence of GDM has exceeded 20% in Asian and African countries [2], posing a huge medical and economic burden. Women with GDM are at an increased risk of developing short- and long-term complications, such as hypertensive disorders during pregnancy [3], perineal trauma [4], and type 2 diabetes (T2D) [5]. Meanwhile, maternal glucose intolerance may promote fetal glucose intake [6], leading to higher risk of large-for-gestational-age (LGA) birth or macrosomia [7], neonatal hypoglycemia [8], and metabolic syndrome during childhood and later life [9]. Lifestyle interventions (including nutrition and physical activity) represent the first-line therapy for GDM [10-12]. Pregnancy nutritional status has a substantial influence on the health status of the women themselves and their offspring [13, 14]. However, it is also well known that different individuals may respond differently to the same diet or nutritional exposures. For example, postprandial response of glucose or other metabolic traits to the same food has been found to be varied among nonpregnant individuals [15, 16]. So far, personalized glycemic responses of pregnant women with GDM to diet/nutritional interventions and their relationship with birth outcomes have not been investigated. Here, we summarized more than 40 birth cohorts worldwide, including sample sizes, strengths, and limitations (Table S1). As we can see, most of these birth cohorts included general pregnancies with large sample sizes. However, multiomics measurements were lacking. Understanding personalized glycemic responses of pregnant women to different dietary challenges can help establish precision nutrition recommendations for pregnant women with GDM, which can further improve the health of these women and their offspring [17, 18]. The emerging technology of continuous glucose monitoring (CGM) makes it convenient for us to monitor glucose fluctuations, postprandial glycemic responses, hyperglycemic and hypoglycemic status, and glycemic variability [19]. Therefore, we have established a birth cohort (Westlake Precision Birth Cohort [WeBirth]) based on pregnant women with GDM, integrating the utilization of wearable devices including CGM and objective measurements of physical activity, standardized testing meals, daily dietary records, and collection of multi-omics data. The purpose of the standardized meal tests is to examine the personalized response to the diet. Our main objective is to explore optimal nutrition recommendations for patients with GDM from the perspective of precision nutrition and the association between personalized blood glucose response and birth outcomes. WeBirth is designed as a prospective cohort study among pregnant women with GDM and their offspring in Hangzhou, China. Figure 1A shows the overview of the study design. In WeBirth, we incorporate three unique components, (1) objective measurement of physical activity during pregnancy using the Axivity AX3 accelerometer (Axivity Ltd.); (2) measurement of dietary intake using both the Food Frequency Questionnaire (FFQ) and a dietary log/record; and (3) measurement of blood glucose levels over 14 days using CGM (Freestyle Libre Pro), with standardized testing meals during the 14-day period. The continuous blood glucose response to daily dietary intake and physical activity, and to facilitate the development of personalized nutritional/lifestyle recommendations among patients with GDM. The association of dietary intake and physical activity with continuous glucose fluctuations during pregnancy on adverse birth outcomes, such as preterm birth, low birth weight (or small-for-gestational-age birth), and macrosomia (or LGA birth). Potential associations of CGM during pregnancy with the body composition of the adult participants after delivery and weight changes of the offspring during early childhood. Risk factors during pregnancy (e.g., continuous glucose characteristics, dietary habits, and oral and gut microbiome) for developing T2D after delivery among women with GDM. Our planned sample size (n = 2000) was based on the literature of precision nutrition studies for multi-omics analyes [15, 16]. WeBirth includes pregnant women attending prenatal care at the Hangzhou Women's Hospital (Hangzhou Maternity and Child Health Care Hospital), China. The recruitment has been initiated since August 2019. Inclusion and exclusion criteria are described below: Pregnant women aged 18 years or older. Pregnant women diagnosed with GDM, with a gestational age mainly ranging from 24 to 28 weeks. Pregnant women intending to deliver at Hangzhou Women's Hospital. Pregnant women intending to remain in Hangzhou with their child for ≥4 years. Pregnant women with cancer or other serious medical disorders. During routine prenatal care, a 2-h 75-g Oral Glucose Tolerance Test is performed on women at 24–28 weeks of pregnancy. We use the International Association of Diabetes and Pregnancy Study Groups criteria for GDM diagnosis (fasting plasma glucose [FPG] ≥ 5.1 mmol/L, and/or 1-h plasma glucose ≥10.0 mmol/L, and/or 2-h plasma glucose ≥8.5 mmol/L) [20]. Our participants are recommended by a nutritionist. After being diagnosed with GDM, pregnant women come to the department of nutrition for dietary counseling on the basis of the recommendation of the obstetrician. The nutritionist conducts an initial screening to exclude those unwilling to wear a CGM device or with extremely poor compliance, and then recommends the remaining patients to our room for the interview. A trained staff further estimates whether their conditions meet the inclusion criteria and their willingness to participate. The median interval between GDM diagnosis and the recruitment into the present study is 0 day (quartile [Q]1 = 0; Q3 = 6). During the baseline visit (visit 1), the staff administer the in-person interview with the participants using different questionnaires to collect information on demography, lifestyle, dietary habits, physical activity, occupational history, and history of medications and family disease. Bone mineral density and body composition are assessed using an ultrasound bone densitometer (Sunlight MiniOmni, BeaMed Co.) and the InBody 720 (Biospace Co., Ltd.), respectively. Each individual is asked to wear a CGM device and an AX3 accelerometer for 14-day blood glucose and physical activity monitoring, respectively. We randomly select some participants to wear CGM devices on both two arms at the same time to verify the stability of the readings. Participants record their dietary intake and nutritional supplements (with an accompanying picture) on an online APP, while wearing the CGM device and the accelerometer. The APP has been developed to support the present study as an electronic dietary log. Meanwhile, the participants report their food intake of the previous day using the 24-h Dietary Recall (24 HR) at recruitment. Biological samples of saliva, blood, urine, and stool are collected. As part of routine health counseling for the pregnant women with hyperglycemia at the Hangzhou Women's Hospital, all these participants are invited to attend a 1-day event/lesson about diet and lifestyle modifications to manage their glycemic status during pregnancy (Figure 1B). The standardized testing meals were developed by the nutritionist according to the Dietary Guide for Patients with Gestational Diabetes Mellitus from the National Health Commission of the People's Republic of China (WS/T 601—2018). During the 1-day event, the standardized meals are prepared in the staff cafeteria of the hospital using standard ingredients: egg, whole wheat flour, celery, and dried bean curd for breakfast; tomato and skim milk as snacks; and rice, oats, shrimp, lettuce, lean pork, carrot, soaked auricularia auricula, broccoli, cucumber, and tomato egg drop soup for lunch (Figure 2A). On the morning of the 1-day event, fasting blood samples (≥8-h fasting) are obtained from the participants to measure the levels of FPG, HbA1c, and vitamin D. Then all the participants are located in an assigned room within the hospital, and have standardized breakfast, snacks, and lunch there. Finger-stick glucose tests are conducted twice after fasting for a 2-h period after breakfast and lunch. Trained nurses/physicians provide pregnancy-related health knowledge to participants through talks between the meals. We follow the participants during the third trimester, during delivery, and after delivery (Figure 1A). During the third trimester (visit 2), a follow-up interview takes place when the pregnant women visit the hospital for prenatal care. We mainly collect data about sleep quality and psychological health using questionnaires at this interview. Simultaneously, repeated measurements of blood pressure, weight, CGM, physical activity, and 24 HR are performed. Biological samples are collected similar to those at baseline. During delivery (visit 3), information on birth outcomes (e.g., gestational age at delivery, birth weight, height, and perinatal medical information) is obtained from the medical records of the prenatal care and delivery clinic. Biological samples of placenta, cord blood, meconium, and colostrum are collected during visit 3. The postpartum follow-up 42 days after delivery (visit 4) is conducted in the hospital when the participants visit the hospital for postnatal care, and mainly, information on feeding practices and growth and development of the infants is collected. Due to the covid pandemic and occasional local virus outbreak and government control, our planned postpartum follow-up at the home of the participants has been considerably disrupted. Therefore, the originally planned follow-up at 6–18 months will have to be modified to follow-up at 6 months to 5 years accordingly for visit 5. The follow-up of visit 5 will be divided into a home visit and a hospital visit. During the home visit, the mothers will fill out a questionnaire aimed at collecting information on dietary habits, lifestyle, and medical history of themselves and their offspring. These mothers will be asked to wear a CGM device again for 14 days and record their daily dietary intake using the APP at the same time. Physical examination and biological sample collection of these women participants will take place at the physical examination center of the Hangzhou Women's Hospital. Anthropometric parameters of the offspring will be measured at the Children's Hospital of Zhejiang University School of Medicine. These children will also undergo different developmental screenings according to their ages, such as hearing screening. Although we will try our best to follow up these participants, loss to follow-up will still be a major issue in a cohort study. Therefore, we will try to encourage the return of these participants to the study center using different strategies, such as special health consulting lessons about child rearing and free health checkups for both mothers and children. As pregnant women with GDM are at high risk of developing T2D after delivery and the offspring are likely to suffer from cardiometabolic diseases during growth [21], we will continue to follow these participants and their offspring longitudinally (Figure 1C). The long-term follow-up will take place every 3 years. Information and biological samples similar to those at visit 5 will be collected during long-term postpartum follow-ups. The long-term follow-up appointment will also include two sections: a home visit and a hospital visit. During the home visit, we will collect information on the dietary habits, lifestyle, and medical history of both the mothers and the offspring using questionnaires. Additionally, physical examination of both the mothers and the children will be conducted at the hospital. The questionnaires have been developed to collect data about demographics, lifestyle, dietary habits, physical activity, occupational history, medical and family disease history, feeding practices, and growth and development of the infants (Figure 3; detailed information is provided in Table 1). Participants complete the questionnaires under the guidance of the staff during face-to-face appointments, except for the questionnaire used to collect information on medical and family disease history at baseline. We have developed an FFQ (Figure 2B) containing 33 items of food/food groups to collect information on dietary habits of our participants, considering the regional characteristics (the Yangtze Delta of China) of dietary intake and the existing questionnaires from Chinese cohorts, including the Guangzhou Nutrition and Health Study [22]. We apply the Chinese version of the Pregnancy Physical Activity Questionnaire (PPAQ-C) [23] and the International Physical Activity Questionnaires, long form (IPAQ-LC) [24] to obtain information on physical activity of participants during pregnancy and after delivery, respectively. The Chinese version of Pittsburgh Sleep Quality Index [25] is used to assess multiple dimensions of sleep quality of participants. Moreover, we utilize the Chinese version of the Self-rating Anxious Scale [26], the Self-rating Depression Scale [27], the Pregnancy-Related Anxiety Questionnaire [28], the Positive and Negative Affect Scale [29], the Edinburgh Postnatal Depression Scale [30], and the Council on Nutrition Appetite Questionnaire [31] for the assessments of psychosocial characteristics, including anxiety, depression, mood (or emotion), and appetite, at different stages of the appointments. All the questionnaires are constructed through on an online platform (“Survey Star,” Changsha Ran Xing Science, and Technology) with the automatic warning of missing data or extremely outrageous value for each variable. Figure 1 presents an overview of biological sample collection across different time points of WeBirth. Saliva samples are collected at the hospital (visits 1 and 2) or at home (visit 5) using tubes with a DNA stabilizer and transferred to a freezer (−40°C) within 10 h after production. Before collecting saliva samples, participants need to wait at least 30 min after eating, drinking, smoking, or chewing, and drink some water to clean the mouth. Fecal samples from pregnant women are collected at the hospital during pregnancy, aliquoted, and stored at −40°C within 1 h after production. We preserve three types of fecal aliquots, including raw feces, feces mixed with an RNA stabilizer, and feces mixed with 50% glycerin. Meconium and colostrum are collected within 3 days after delivery, kept at 4°C temporarily, and transferred to a −40°C freezer within 15 h of collection. For the postpartum visits, fecal samples from mothers or their offspring are collected into tubes with a DNA stabilizer at home and transferred (room temperature) to the laboratory for aliquot and storage at −40°C within 3 days of collection. Specimens of midstream urine and breastmilk are collected at the hospital, immediately placed at 4°C, aliquoted, and stored at −40°C within 3 h of collection. All serum samples and most whole-blood samples are collected after at least 8 h of fasting (whole-blood samples of the third trimester are sampled randomly). All blood samples are kept at 4°C temporarily after collection. Then, plasma, white cell, red cell, and serum samples are aliquoted and stored in a −40°C freezer. Cord blood samples are collected by nurses using lavender stopper BD Vacutainer K2EDTA tubes in the delivery room. Two fragments (1 cm3) of fetal-surface placenta are collected within 1 cm from the umbilical cord. Samples of cord blood and placenta are kept at 4°C immediately and stored at −40°C within 24 h after collection. Placenta samples are mixed with a DNA stabilizer before being transferred to a −40°C freezer. All the biological samples mentioned above are frozen temporarily at −40°C in the hospital. Within 1 of all the biological samples are on to Westlake University to be stored at For blood samples, measurements of common such as types and blood blood and and are assessed using automatic in the laboratory of the hospital. Additionally, blood samples of some of the participants have been used for and according to the existing For DNA is from blood using the DNA Co., DNA are using the DNA is stored at further We apply containing for and for quality and is performed using the the are from and then using over a min on a to an Saliva and fecal samples are mainly for including and 2 The of have been The DNA is using the DNA according to the DNA quality is by All the DNA samples are stored at For the of the are from DNA with using the are conducted according to the 3 min of at 28 of 30 at 30 for at and for at and a at for 10 The of are with by The are conducted according to the 3 min of at of 30 at 30 for at and for at and a at for 10 of or are in and on an platform the standard of Co., For we fecal DNA based on the DNA the The and of DNA are assessed using a with and respectively. The DNA is kept at for further We the DNA to with of according to the DNA Each is by the platform with the at Co., with at least 10 of raw data data will be and using The CGM will be to different glycemic such as time glucose under the and of We will the associations of glycemic with dietary physical activity, and birth outcomes using For will be to the 3 by will be conducted using the 3 by We will use the in a to the of by all We will further a of based on the and data. For we will the in such as the measure of measure of and the (or the a measure of between groups by different study using the or association with or will be used for the of such as and or will be performed to in each data We will further of different data using (e.g., and We have included pregnant women with GDM in WeBirth up to for complete data of the characteristics were obtained at recruitment (Table from to years = = with being than years of The body and gestational age at recruitment are and respectively. than of the pregnant women are of the participants of the participants are as those a drink containing at least a on in the The participants have an daily dietary intake of based on the WeBirth is a prospective cohort study of women participants with GDM and their offspring. Participants standardized testing meals and undergo objective measurements of physical activity and continuous blood glucose for 14 dietary records during this period. We have quality quality is the study to high quality of data collection. As mentioned we for missing data or extremely outrageous value for each in the questionnaires. Biological samples are aliquoted, and assessed standardized Information on dietary habits and physical activity is collected using different and daily dietary the and wearable accelerometer for monitoring physical which can be used for the measurement of during the 1-day and wearing of the CGM device on both two arms can testing of the stability and quality of CGM readings. The unique study us to explore the personalized glycemic response to nutrition and physical Simultaneously, the of characteristics at different including physical lifestyle psychosocial characteristics, medical records, and multiomics The present study has our cohort includes Chinese participants, the may not be to other our study includes participants with GDM, with the of a at this to the of the cohort we not establish based on the cohort data. In WeBirth provides a new framework for a prospective birth cohort study with sophisticated integration of precision nutrition, wearable devices, and collection of multi-omics data among patients with GDM. from WeBirth will represent a unique and will to our knowledge of precision nutrition for GDM risk factors for adverse birth outcomes, and factors the long-term health of pregnant women with GDM and their offspring. was in the of the and and of the study. was in the of the and and of the study. was in the data of the of the and and of the study. was in the of the and and of the study. was in the of the study and of the and was in the and data of the study and of the and was in the and of the study and of the and was in the of the study and of the and was in the of the study and of the and was in the of the and and of the study. was in the and of the and of the and was in the and data of the study and of the and was in the of the study and of the and was in of the study and of the and was in of the study and of the and was in of the study and of the and was in of the study and of the and was in of the study and of the and was in the of the and and of the study. The all the participants in the present study. study was by the National of China the National of China and the Zhejiang of China and the of Westlake of and the and of Zhejiang the National Health Commission and of and Health of Zhejiang and the and of and Health of Hangzhou and The in the study data collection and to or of the The of WeBirth was by the of Westlake University was obtained from each of the data are not at this the for the Chinese and may be found in the online or The is not for the or of information by the than missing be to the for the
BibTeX
@inproceedings{liang2023integration,
author = {Xinxiu Liang and Zelei Miao and Sha Lu and Meng Ye and Jiali Wang and Hui Zhao and Congmei Xiao and Menglei Shuai and Wanglong Gou and Yuhui Liang and Fengzhe Xu and Meiqi Shi and Yingying Wu and Xuhong Wang and Fengcheng Cai and Mengyan Xu and Yuanqing Fu and Wensheng Hu and Ju‐Sheng Zheng},
title = {{Integration of multiomics with precision nutrition for gestational diabetes: Study protocol for the Westlake Precision Birth Cohort}},
booktitle = {iMeta},
year = {2023},
doi = {10.1002/imt2.96},
}